Status:
COMPLETED
Statins in Patients With Spontaneous Intracerebral Hemorrhage
Lead Sponsor:
Pomeranian Medical University Szczecin
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
36-95 years
Phase:
NA
Brief Summary
The relation between improvement in results of treating spontaneous intracerebral hemorrhage (SICH) and the application of statins has been subject to numerous analyses, and yet still remains debatabl...
Detailed Description
The relation between improvement in results of treating spontaneous intracerebral hemorrhage (SICH) and the application of statins has been subject to numerous analyses, and yet still remains debatabl...
Eligibility Criteria
Inclusion
- Age over 18 years old
- Spontaneous intracerebral hemorrhage confirmed by computed tomography/MRI of the head
- Taking statins: rosuvastatin or atorvastatin for at least 6 months - applies only to group II
Exclusion
- Secondary central nervous system bleeding (e.g. tumor, vascular malformation, haemorrhaged ischemic stroke, coagulopathy, anticoagulant therapy)
- SAH/traumatic bleeding
- Accompanying ischemic focus in the brain
- Infection with fever and/or high inflammatory parameters on the day of admission to the hospital
- Age under 18 years old
Key Trial Info
Start Date :
March 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 17 2021
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT06094244
Start Date
March 17 2017
End Date
March 17 2021
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pomeranian Medical University
Szczecin, West Pomeranian Voivodeship, Poland, 58-400